Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$290K Sell
6,790
-2,145
-24% -$95.8K 0.05% 340
2026
Q1
$430K Buy
8,935
+236
+3% +$11K 0.09% 229
2025
Q4
$422K Buy
+8,699
New +$431K 0.09% 221

Other funds holding SNY

PCM Encore's SNY Position: Q2 2026 in Review

PCM Encore reduced its Sanofi (SNY) stake by 24% in Q2 2026, selling an estimated $95.8K and leaving 6,790 shares worth $290K. The position accounts for 0.05% of the portfolio, ranked #340.

PCM Encore first reported a position in SNY in Q4 2025 and has held it in 3 quarters since. The position peaked at $430K in Q1 2026. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • PCM Encore held 6,790 shares of Sanofi worth $290K as of Q2 2026.
  • PCM Encore sold 2,145 Sanofi shares in Q2 2026, an estimated $95.8K.
  • Sanofi made up 0.05% of PCM Encore's portfolio in Q2 2026, its #340 holding.
  • PCM Encore first reported a position in Sanofi in Q4 2025 and has held it in 3 quarters since.
  • PCM Encore's Sanofi position peaked at $430K in Q1 2026.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on PCM Encore's 13F filing for Q2 2026, filed 11 Aug 2026.